Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma

This subset analysis of data from two phase III studies in patients with relapsed or refractory multiple myeloma (MM) evaluated the benefit of initiating lenalidomide plus dexamethasone at first relapse. Multivariate analysis showed that fewer prior therapies, along with β(2)-microglobulin (≤2.5 mg/...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Stadtmauer, Edward A, Weber, Donna M, Niesvizky, Ruben, Belch, Andrew, Prince, Miles H, San Miguel, Jesús F, Facon, Thierry, Olesnyckyj, Marta, Yu, Zhinuan, Zeldis, Jerome B, Knight, Robert D, Dimopoulos, Meletios A
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2009
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2704925/
https://ncbi.nlm.nih.gov/pubmed/19302559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0609.2009.01257.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk